Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
2(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
50%
Ph phase_4
5
42%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
5(45.5%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(9)
Other(1)

Detailed Status

Completed9
Active, not recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 45 (45.5%)
N/A6 (54.5%)

Trials by Status

active_not_recruiting18%
unknown18%
completed975%
recruiting18%

Recent Activity

2 active trials
Showing 5 of 12
active_not_recruitingnot_applicable

Swedish Microinvasive Glaucoma Surgery Study (SMIGS)

NCT05035394
completednot_applicable

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01252849
completednot_applicable

Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty

NCT01444105
completednot_applicable

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01517477
unknownnot_applicable

Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery

NCT01841450
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05035394Not Applicable

Swedish Microinvasive Glaucoma Surgery Study (SMIGS)

Active Not Recruiting
NCT01252849Not Applicable

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Completed
NCT01444105Not Applicable

Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty

Completed
NCT01517477Not Applicable

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Completed
NCT01841450Not Applicable

Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery

Unknown
NCT04635020Not Applicable

Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group

Recruiting
NCT01841437

Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry

Completed
NCT01443988Phase 4

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost

Completed
NCT01252862Phase 4

Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents

Completed
NCT00326014Phase 4

A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.

Completed
NCT00913029Phase 4

Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

Completed
NCT00911924Phase 4

A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma

Completed

All 12 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
12